Indaptus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 256.27 K | $140.95 K | 0.00% | 1.82% |
| INVESTMENT HOUSE LLC | 05/08/2025 | 128.85 K | $70.86 K | 28.62% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 124.97 K | $68.72 K | 52.18% | 0.89% |
| STRATEGY ASSET MANAGERS LLC | 05/09/2025 | 45.34 K | $24.93 K | 0.00% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 28.50 K | $15.67 K | 2.89% | 0.20% |
| VIVALDI CAPITAL MANAGEMENT LP | 05/15/2025 | 24.00 K | $13.20 K | 0.00% | 0.17% |
| STATE STREET CORP | 05/15/2025 | 13.07 K | $7.19 K | 0.00% | 0.09% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 12.87 K | $7.00 K | 100.00% | 0.09% |
| SBI SECURITIES CO., LTD. | 05/02/2025 | 4.40 K | $2.42 K | 12.82% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.49 K | $1.92 K | -0.57% | 0.02% |
| MORGAN STANLEY | 05/15/2025 | 884 | $486 | 0.00% | 0.01% |
| BANGOR SAVINGS BANK | 04/14/2025 | 350 | $192 | -12.50% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 98 | $54 | 60.66% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 87 | $49 | -96.55% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 64 | $35 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 17 | $9 | -10.53% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 7 | $4 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Indaptus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Indaptus Therapeutics, Inc.. The most heavily invested institutionals were:
Pine Valley Investments Ltd Liability Co: 43,921
REILLY FINANCIAL ADVISORS, LLC: 63
4.56% of Indaptus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 43.98 K shares in the last 24 months. This purchase volume represents approximately $143.83 K in transactions.